EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitMetaanalyseOpen Access · CC BY 4.0

Soluble fms-like tyrosine kinase-1 and peripartum cardiomyopathy: an exploratory meta-analysis of association and diagnostic performance

Triwedya Indra Dewi, William Kamarullah, Hawani Sasmaya Prameswari, Chaerul Achmad, Ruswana Anwar, Delvac Oceandy, Firman Fuad Wirakusumah

Frontiers in Cardiovascular Medicine · 08.06.2026 · 13

DOI: 10.3389/fcvm.2026.1825532 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 08.06.2026. Verfasst von Triwedya Indra Dewi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Vascular Medicine, Faculty of Medicine, Padjadjaran University, Hasan Sadikin General Hospital, Bandung, Indonesia. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Peripartum cardiomyopathy (PPCM) is a rare cause of heart failure in late pregnancy and early postpartum, and biomarkers for risk stratification are lacking. Soluble fms-like tyrosine kinase-1 (sFlt-1), implicated in PPCM and pre-eclampsia, may be associated with PPCM and may have potential diagnostic relevance. This study aimed to evaluate the association between circulating sFlt-1 levels and PPCM and to provide an exploratory assessment of the diagnostic performance of sFlt-1 overall and according to pre-eclampsia status.

Methods

We searched PubMed, Europe PMC, and ScienceDirect from inception to 15th February 2026 for studies reporting sFlt-1 in PPCM cases and pregnant or postpartum controls. Given the rarity of PPCM and the limited number of eligible studies, this review was designed as an exploratory meta-analysis. Random-effects models pooled odds ratios (ORs) for PPCM comparing high vs. low sFlt-1 and enabled subgroup analyses by pre-eclampsia. I Diagnostic performance was summarised using pooled sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC).

Results

Three studies ( n = 226) met the criteria. High sFlt-1 levels were associated with increased PPCM risk [pooled OR 1.79; 95% confidence interval (CI) 1.22–2.64], although substantial heterogeneity was present across studies. In exploratory diagnostic analyses, performance was modest, with sensitivity 72% (95% CI 64%–80%), specificity 57% (95% CI 44%–68%), and AUC 0.71 (95% CI 0.67–0.75). In women with pre-eclampsia, the association with PPCM was stronger (OR 2.11; 95% CI 1.45–3.09) than in those without pre-eclampsia (OR 1.36; 95% CI 1.03–1.80), with higher sensitivity and specificity.

Conclusion

Elevated sFlt-1 was associated with PPCM, with exploratory analyses suggesting somewhat better diagnostic discrimination in women with pre-eclampsia. However, because all included studies measured sFlt-1 in the postpartum period, these findings should not be interpreted as evidence for antepartum screening utility. Larger prospective studies with measurements during pregnancy and serial peripartum follow-up are needed before any clinical application can be considered. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/view/CRD42024535557 , identifier (CRD42024535557).

Schlagwörter

Stichwörter der Autor:innen

biomarkermeta-analysisperipartum cardiomyopathysFlt-1soluble fms-like tyrosine kinase-1

Autor:innen und Institutionen

  • Department of Cardiology and Vascular Medicine, Faculty of Medicine, Padjadjaran University, Hasan Sadikin General Hospital, Bandung, Indonesia.
  • Department of Obstetrics and Gynecology, Faculty of Medicine, Padjadjaran University, Hasan Sadikin General Hospital, Bandung, Indonesia.
  • Division of Cardiovascular Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.

Zitieren

APA

Dewi, T. I., Kamarullah, W., Prameswari, H. S., Achmad, C., Anwar, R., Oceandy, D., & Wirakusumah, F. F. (2026). Soluble fms-like tyrosine kinase-1 and peripartum cardiomyopathy: an exploratory meta-analysis of association and diagnostic performance. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1825532

Vancouver

Dewi TI, Kamarullah W, Prameswari HS, Achmad C, Anwar R, Oceandy D, et al. Soluble fms-like tyrosine kinase-1 and peripartum cardiomyopathy: an exploratory meta-analysis of association and diagnostic performance. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1825532

BibTeX
@article{Dewi2026,
  author = {Dewi, Triwedya Indra and Kamarullah, William and Prameswari, Hawani Sasmaya and Achmad, Chaerul and Anwar, Ruswana and Oceandy, Delvac and Wirakusumah, Firman Fuad},
  title = {Soluble fms-like tyrosine kinase-1 and peripartum cardiomyopathy: an exploratory meta-analysis of association and diagnostic performance},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1825532}
}
Kostenlos starten →